Mechanical Valve Divestiture Is Defining Move For MedicalCV’s New CEO
This article was originally published in The Gray Sheet
Executive Summary
MedicalCV will conduct an IDE clinical study to investigate its Atrilaze soft tissue ablation system for cardiac arrhythmias, following an initial 510(k) clearance